Global Adult Hemoglobinopathy Testing Market by Group (Structural Hemoglobin Variants, Thalassemia Syndromes), Type (Hb Electrophoresis, HPLC Detection, Mass Spectrometry), End-Use - Forecast 2024-2030- Product Image

Sale

Global Adult Hemoglobinopathy Testing Market by Group (Structural Hemoglobin Variants, Thalassemia Syndromes), Type (Hb Electrophoresis, HPLC Detection, Mass Spectrometry), End-Use - Forecast 2024-2030

Report
180 Pages
March 2024
Region: Global
360iResearch™
ID: 5887529

UP TO €844EUR$875USD£724GBP OFF until Dec 31^st 2024

The Adult Hemoglobinopathy Testing Market size was estimated at USD 4.72 billion in 2023, USD 5.10 billion in 2024, and is expected to grow at a CAGR of 6.17% to reach USD 7.18 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Adult Hemoglobinopathy Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Adult Hemoglobinopathy Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Adult Hemoglobinopathy Testing Market, highlighting leading vendors and their innovative profiles. These include ARKRAY, Inc., Beckman Coulter, Inc. by Danaher Corporation, Bio-Rad Laboratories, Inc., Bluebird Bio, Inc., Creative Diagnostics, F. Hoffmann-La Roche Ltd., HORIBA Group, Illumina, Inc., Laboratory Corporation of America Holdings, Merck KGaA, PerkinElmer, Inc., Quest Diagnostics Incorporated, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Shimadzu Corporation, Siemens Healthineers AG, Sysmex Europe SE, Thermo Fisher Scientific Inc., Tosoh Corporation, and Trinity Biotech PLC.

Market Segmentation & Coverage

This research report categorizes the Adult Hemoglobinopathy Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Group
- Structural Hemoglobin Variants
- Thalassemia Syndromes
Type
- Hb Electrophoresis
- HPLC Detection
- Mass Spectrometry
End-Use
- Hospital
- Laboratories
- Medical & Research Institute

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

What is the market size and forecast of the Adult Hemoglobinopathy Testing Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Adult Hemoglobinopathy Testing Market?
What are the technology trends and regulatory frameworks in the Adult Hemoglobinopathy Testing Market?
What is the market share of the leading vendors in the Adult Hemoglobinopathy Testing Market?
Which modes and strategic moves are suitable for entering the Adult Hemoglobinopathy Testing Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Adult Hemoglobinopathy Testing Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of thalassemia and sickle cell disease (SCD) worldwide
5.1.1.2. Inclination toward early diagnosis and treatment of diseases
5.1.1.3. Ongoing newborn screening programs and need for accurate and reliable testing methodologies
5.1.2. Restraints
5.1.2.1. High cost associated with adult-hemoglobinopathy-testing
5.1.3. Opportunities
5.1.3.1. Technological advancements in adult-hemoglobinopathy-testing methods
5.1.3.2. Ongoing research and development on adult-hemoglobinopathy
5.1.4. Challenges
5.1.4.1. Technical limitations in devices used for adult-hemoglobinopathy-testing
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Adult Hemoglobinopathy Testing Market, by Group

6.1. Introduction
6.2. Structural Hemoglobin Variants
6.3. Thalassemia Syndromes

7. Adult Hemoglobinopathy Testing Market, by Type

7.1. Introduction
7.2. Hb Electrophoresis
7.3. HPLC Detection
7.4. Mass Spectrometry

8. Adult Hemoglobinopathy Testing Market, by End-Use

8.1. Introduction
8.2. Hospital
8.3. Laboratories
8.4. Medical & Research Institute

9. Americas Adult Hemoglobinopathy Testing Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Adult Hemoglobinopathy Testing Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Adult Hemoglobinopathy Testing Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

13.1. Key Company Profiles
13.1.1. ARKRAY, Inc.
13.1.2. Beckman Coulter, Inc. by Danaher Corporation
13.1.3. Bio-Rad Laboratories, Inc.
13.1.4. Bluebird Bio, Inc.
13.1.5. Creative Diagnostics
13.1.6. F. Hoffmann-La Roche Ltd.
13.1.7. HORIBA Group
13.1.8. Illumina, Inc.
13.1.9. Laboratory Corporation of America Holdings
13.1.10. Merck KGaA
13.1.11. PerkinElmer, Inc.
13.1.12. Quest Diagnostics Incorporated
13.1.13. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
13.1.14. Shimadzu Corporation
13.1.15. Siemens Healthineers AG
13.1.16. Sysmex Europe SE
13.1.17. Thermo Fisher Scientific Inc.
13.1.18. Tosoh Corporation
13.1.19. Trinity Biotech PLC
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. ADULT HEMOGLOBINOPATHY TESTING MARKET RESEARCH PROCESS
FIGURE 2. ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ADULT HEMOGLOBINOPATHY TESTING MARKET DYNAMICS
FIGURE 7. ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2023 VS 2030 (%)
FIGURE 8. ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 10. ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 12. ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ADULT HEMOGLOBINOPATHY TESTING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. ADULT HEMOGLOBINOPATHY TESTING MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. ADULT HEMOGLOBINOPATHY TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 6. ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY STRUCTURAL HEMOGLOBIN VARIANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA SYNDROMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 9. ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HB ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HPLC DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 13. ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MEDICAL & RESEARCH INSTITUTE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 20. ARGENTINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 23. BRAZIL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 26. CANADA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 27. CANADA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 28. CANADA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 29. MEXICO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 30. MEXICO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. MEXICO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 36. ASIA-PACIFIC ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 40. AUSTRALIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 41. AUSTRALIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 43. CHINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 44. CHINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. CHINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 46. INDIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 47. INDIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. INDIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 49. INDONESIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 52. JAPAN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 53. JAPAN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. JAPAN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 55. MALAYSIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 56. MALAYSIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 58. PHILIPPINES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 59. PHILIPPINES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 61. SINGAPORE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 62. SINGAPORE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 64. SOUTH KOREA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 65. SOUTH KOREA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 67. TAIWAN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 68. TAIWAN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 70. THAILAND ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 71. THAILAND ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. THAILAND ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 73. VIETNAM ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 74. VIETNAM ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 80. DENMARK ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 81. DENMARK ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. DENMARK ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 83. EGYPT ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 84. EGYPT ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. EGYPT ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 86. FINLAND ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 87. FINLAND ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. FINLAND ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 89. FRANCE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 90. FRANCE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. FRANCE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 92. GERMANY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 93. GERMANY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. GERMANY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 95. ISRAEL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 98. ITALY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 99. ITALY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. ITALY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 101. NETHERLANDS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 104. NIGERIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 105. NIGERIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 107. NORWAY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 108. NORWAY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. NORWAY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 110. POLAND ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 111. POLAND ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. POLAND ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 113. QATAR ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 114. QATAR ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. QATAR ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 116. RUSSIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 122. SOUTH AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 125. SPAIN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 126. SPAIN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. SPAIN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 128. SWEDEN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 131. SWITZERLAND ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 134. TURKEY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 135. TURKEY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. TURKEY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 137. UNITED ARAB EMIRATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 143. ADULT HEMOGLOBINOPATHY TESTING MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 144. ADULT HEMOGLOBINOPATHY TESTING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 145. ADULT HEMOGLOBINOPATHY TESTING MARKET LICENSE & PRICING

Companies Mentioned

ARKRAY, Inc.
Beckman Coulter, Inc. by Danaher Corporation
Bio-Rad Laboratories, Inc.
Bluebird Bio, Inc.
Creative Diagnostics
F. Hoffmann-La Roche Ltd.
HORIBA Group
Illumina, Inc.
Laboratory Corporation of America Holdings
Merck KGaA
PerkinElmer, Inc.
Quest Diagnostics Incorporated
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Shimadzu Corporation
Siemens Healthineers AG
Sysmex Europe SE
Thermo Fisher Scientific Inc.
Tosoh Corporation
Trinity Biotech PLC

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	180
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 5.1 Billion
Forecasted Market Value ( USD ) by 2030	$ 7.18 Billion
Compound Annual Growth Rate	6.1%
Regions Covered	Global
No. of Companies Mentioned	19

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3257EUR$3,374USD£2,794GBP €3619EUR$3,749USD£3,104GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4125EUR$4,274USD£3,539GBP €4584EUR$4,749USD£3,932GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€4994EUR$5,174USD£4,284GBP €5549EUR$5,749USD£4,760GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5863EUR$6,074USD£5,029GBP €6514EUR$6,749USD£5,588GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7600EUR$7,874USD£6,519GBP €8445EUR$8,749USD£7,244GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects

The report addresses key questions such as

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Adult Hemoglobinopathy Testing - Global Strategic Business Report

Global Hemoglobin Testing Market by Type (Blood Glucose Testing, Cyanmethemoglobin Method, Hemoglobin Electrophoresis), Technology (Laboratory Testing, Point-of-Care Testing), Operation, Application, End-User - Forecast 2024-2030

Global Glycated Hemoglobin Testing Market by Type (Laboratory Based Tests, Point-Of-Care Test), Technique (Boronate Affinity Chromatography, Direct Enzymatic Assay, High-Performance Liquid Chromatography), End-User - Forecast 2024-2030

Hemoglobin A1C (HbA1C) Testing - Global Strategic Business Report

Hemoglobin A1c Testing Devices Global Market Report 2024